[{"Assets_0_Q1_USD":6119500000.0,"CommonStockSharesConverted_0_Q1_shares":146235714.0,"CommonStockSharesOutstanding_0_Q1_shares":146235714.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":25200000.0,"RevenuesConverted_1_Q1_USD":664700000.0,"StockholdersEquity_0_Q1_USD":1649300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":145663115.0,"StockholdersEquityConverted_0_Q1_USD":1649300000.0,"EarningsPerShareBasic_1_Q1_USD":-0.05,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":145663115.0,"NetIncomeLossConverted_1_Q1_USD":-8000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.05,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20191105"}]